Pursuant to Regulation 30 read with Part-A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Beryl Drugs has informed that the Board of Directors in its 35th Board Meeting held on 11.08.2021 has approved the Unaudited Financial Results of the Company for the Quarter ended 30.06.2021.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 779.35 |
| Dr. Reddy's Lab | 4744.30 |
| Aurobindo Pharma | 856.85 |
| Lupin | 1050.20 |
| Cadila Healthcare | 563.65 |
| View more.. | |